Viewing Study NCT03608033

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-05-01 @ 12:27 AM
Study NCT ID: NCT03608033
Status: TERMINATED
Last Update Posted: 2025-12-09
First Post: 2018-06-21
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Sponsor: Omeros Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None IgA Nephropathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IgA nephropathy View
None IgAN View
None Proteinuria View
None Chronic kidney disease View
None IgAN autoantibodies View
None eGFR View
None EGFR slope View
None UPE View
None Narsoplimab View